Abstract:Abstract Background Preeclampsia is a severe complication of pregnancy that can impose a significant economic burden and pose a serious threat to the health of both mothers and infants. Currently, there are no effective treatment methods for established preeclampsia other than delivering the placenta. Methods We performed differential analysis and weighted correlation network analysis (WGCNA) on RNA-seq datasets to identify highly associated blood system biomarkers in preeclampsia. The expression levels and potential predictive value of these biomarkers were validated through ELISA experiments. Subsequently, multiple bioinformatics analyses were conducted to predict the biological activities and gene mappings of the selected genes. The changes in the proportions of blood immune cells and abnormal cell-cell communication in the pathogenesis of preeclampsia were explored through analysis of single-cell transcriptomics data from blood samples. Potential candidate drugs were predicted using the DrugBank database. Results We identified and preliminarily validated the expression levels of F2R Like Trypsin Receptor 1 (F2RL1) and Granzyme H (GZMH) in maternal blood samples from preeclampsia through quantitative experiments. Gene Set Enrichment Analysis (GSEA) indicated that F2RL1 is involved in the regulation of classical signaling pathways, including Toll-like receptor signaling pathway, pattern recognition receptor signaling pathway, oxidative stress-induced intrinsic apoptotic signaling pathway, and vesicle targeting processes. GZMH is primarily involved in immune processes associated with natural killer cells and also regulates lymphocyte chemotaxis. Analysis of single-cell sequencing datasets revealed significant changes in T cells and hematopoietic Stem Cell Growth Factor (HSC G-CSF) in the maternal blood system during the pathogenesis of preeclampsia. Receptor-ligand analysis and protein-drug analysis highlighted the important role of aspirin in the treatment of preeclampsia, as well as the potential value of tyrosine kinase inhibitors in preeclampsia treatment. Conclusion: This study identified the preeclampsia biomarkers F2RL1 and GZMH, which showed good diagnostic value, and predicted their potential biological functions. The disrupted immune environment in the maternal blood system and potential therapeutic drugs were explored through single-cell transcriptomics data analysis. This research provides new insights for the prediction of preeclampsia and deepens our understanding of the changes in the maternal blood system's immune environment during preeclampsia. However, further laboratory work and multicenter clinical evidence are still needed to clarify the clinical prospects of these findings.

Bioinformatics Methods in Biomarkers of Preeclampsia and Associated Potential Drug Applications

Prediction of Differentially Expressed Genes and a Diagnostic Signature of Preeclampsia Via Integrated Bioinformatics Analysis

Identifying Key Genes and Drug Screening for Preeclampsia Based on Gene Expression Profiles

Detection and assessment of immune and stromal related risk genes to predict preeclampsia: A bioinformatics analysis with dataset

Bioinformatics-based Identification of Mirna-, Lncrna-, and Mrna-Associated Cerna Networks and Potential Biomarkers for Preeclampsia.

Single-Cell RNA Sequencing and Microarray Analysis Reveal the Role of Lipid-Metabolism-Related Genes and Cellular Immune Infiltration in Pre-Eclampsia and Identify Novel Biomarkers for Pre-Eclampsia

An integrative bioinformatics analysis of microarray data for identifying hub genes as diagnostic biomarkers of preeclampsia

Identification and validation of an angiogenesis-related signature associated with preeclampsia by bioinformatic analysis

Integration of Single-Cell Sequencing and Transcriptomic Analysis to Identify Novel Diagnostic Biomarkers for Preeclampsia and Explore Changes in Immune Cell Interactions

Inflammation in Preeclampsia: Genetic Biomarkers, Mechanisms, and Therapeutic Strategies

Potential Of Immune-Related Genes As Biomarkers For Diagnosis And Subtype Classification Of Preeclampsia

Identification Of Key Genes In Preeclampsia-Associated Trophoblast Cells Using Bioinformatics Analysis

Machine Learning and Bioinformatics Framework Integration Reveal Potential Characteristic Genes Related to Immune Cell Infiltration in Preeclampsia.

A Potential Autophagy-Related-Gene Based Signature in Patients with Preeclampsia

Comprehensive Analysis of Differently Expressed and Methylated Genes in Preeclampsia

Bioinformatics analysis identifies potential autophagy key genes and immune infiltration in preeclampsia

Mechanistic study of pre-eclampsia and macrophage-associated molecular networks: bioinformatics insights from multiple datasets

Identification of hub glutamine metabolism-associated genes and immune characteristics in pre-eclampsia

Development and validation of preeclampsia predictive models using key genes from bioinformatics and machine learning approaches

A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles-derived transcriptomic biomarkers in early-onset preeclampsia

Identifying molecular subgroups of patients with preeclampsia through bioinformatics